Jasmin Straube

Bioinformatician-Post doc researching myeloid blood cancers @QIMRBerghofer with @StevenLane_QIMR

[NDLR Conference @NDLR_conference]

🚨 Call for Abstracts Now Open #NDLR2026 🚨

Only 1 week left to submit your abstracts!

🗓 Abstract submission closes 23 September 2025
🩸 Submit now: https://t.co/NF7po9GDcq

[NDLR Conference @NDLR_conference]

We are thrilled to introduce our new #NDLR2026 Meet-the-Editor session, with esteemed Editors-in-Chief, Prof. Andrew Roberts Roberts from Blood and Prof. Jan Cools, @Hemasphere_EHA who will share their invaluable insights on publishing in high-impact hematology journals.

[NDLR Conference @NDLR_conference]

We are honoured to welcome clinician-scientist Prof @StevenLane_QIMR from @QIMRB_Institute as a speaker to #NDLR2026. Steven’s research concentrates on understanding how #leukemia stem cells in #AcuteMyeloidLeukemia and #MyeloproliferativeNeoplasm can regenerate leukemia.

[NDLR Conference @NDLR_conference]

We are honoured to welcome Professor John D. Crispino, from @StJude as speaker to #NDLR2026. John’s research focuses on mechanisms of #Leukemia development in children with Down syndrome and the malignant progression of #MyelodysplasticSyndrome and #MyeloproliferativeNeoplasms.

[NDLR Conference @NDLR_conference]

We are happy to announce some key dates for NDLR 2026. Hope to see you there!

[NDLR Conference @NDLR_conference]

A huge thank you to @LeukaemiaAus for sponsoring NDLR 2026!

[NDLR Conference @NDLR_conference]

We are excited to announce that Dr Elliot Stieglitz will be joining us at NDLR 2026. Hope to see you there. #NDLR2026

[NDLR Conference @NDLR_conference]

We are happy to announce that Dr Jad Othman will be coming to Adelaide for NDLR 2026. #NDLR2026

[NDLR Conference @NDLR_conference]

We are pleased to announce that A/Prof Jessica Nordlund will be joining us in Adelaide at #NDLR2026.

[NDLR Conference @NDLR_conference]

We are please to announce that Dr Lindsey Montefiori will be joining us as an invited speaker for NDLR 2026. #NDLR2026

[NDLR Conference @NDLR_conference]

We are pleased to announce the first of our invited speakers for the NDLR 2026 program Prof Ari Melnick @LabMelnick. #NDLR2026

[NDLR Conference @NDLR_conference]

The Scientific and Organising Committees would like to invite you to be a part of the New Directions in Leukaemia Research (NDLR) Meeting 2026 being held in Adelaide, Australia Mon 2 March - Wed 4 March 2026.

[Cancer Discovery @CD_AACR]

#OnlineFirst: Jak2V617F Reversible Activation Shows Its Essential Requirement in #MyeloproliferativeNeoplasms, by @JAK2TheFuture, @bowman_rl, @rosslevinemd, @RossLevineLab et al.
https://t.co/1JHjBPFSkQ
@MSKCancerCenter #mpnsm

[Florian Perner @florian_perner]

We are hiring!
My laboratory at Hannover Medical School is searching for a motivated postdoc to join our team for the work on a highly competitive research project in the field of chromatin biology in pre-malignant hematopoiesis.
Interested? Apply here: https://t.co/Oo1QeL0oyr

[Alejo Rodriguez-Fraticelli @AlejoFraticelli]

A superteam of @JswLab and @bloodgenes presents a technical tour de force in the mtDNA lineage tracing field. Congrats to authors!

[Jasmin Straube @JStraubeBioinfo]

Only at #EHA2023 you get to have a drink with a tea rex.

[Jasmin Straube @JStraubeBioinfo]

Super excited to head to @EHA_Hematology #EHA2023 with the fambam and present our new data on #Myc driven immune escape in #AML of our recently published paper https://t.co/0q472WuOny. Hope to see many of you nice and early at the Molecular Hematopoiesis Workshop Friday 8am! 😀

[Jasmin Straube @JStraubeBioinfo]

Study unravelling imetelstat treatment mechanism in AML by our teams talented Dr Claudia Bruedigam @cbruedigam in preprint. Check it out!

[bioRxiv @biorxivpreprint]

Imetelstat-Mediated Alterations in Fatty Acid Metabolism To Induce Ferroptosis As Therapeutic Strategy for Acute Myeloid Leukemia https://t.co/C3pkujQVU4 #bioRxiv

[Evris Gavathiotis @ProfGavathiotis]

Excited to share our new paper on "Mitophagy promotes resistance to BH3 mimetics in acute myeloid leukemia" @CD_AACR. Amazing collaboration with @iannisaifantis1 lab ,@glytsou @xufeng_chen . Work from our lab spearheaded by Manos Zacharioudakis. Congrats to all authors!

[Steve Lane @StevenLane_QIMR]

Our latest work. We examine immune responses in Acute Myeloid Leukaemia (AML). The oncogene that drives the AML also specifies the intensity and type of immune response. #immunotherapy
Work by
@rebeccajaustin1
@JStraubeBioinfo
@megan_bywater
@NatureComms
https://t.co/hTiRgccTWP